Latest

Antimalarial

Home Antimalarial

Antimalarial

National Academies to Study Long-Term Psychiatric Effects of Antimalarial Drugs

January 9, 2019

SiteWatch: Washington University Expands Mission of McDonnell Genome Institute

February 16, 2019

Clinical Trials Software Vendor Teckro Raises $25 Million Series C

February 16, 2019

Stanford University Seeks Human Resources Administrator For the Cancer Clinical Trials Office

February 16, 2019

A Desperate Attempt to Save a Drug or a Positive Presentation Moving Forward?

February 16, 2019

TrialSite News is the only digital media dedicated 100% to transparent and open coverage of clinical research trial sites around the globe. Based in the Silicon Slopes in downtown Salt Lake City, Utah, we are founded by a team of experts in the clinical trials industry and dedicated to transparency, quality and clinical trial innovation.

307 West 200 South #5002
Salt Lake City, UT 84101
Contact us: admin@trialsitenews.com

Privacy Policy

Contact

© TrialSite News, Inc. All Rights Reserved

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site you consent to our use of cookies.Ok

Edit with Live CSS

Save
Write CSS OR LESS and hit save. CTRL + SPACE for auto-complete.

National Academies to Study Long-Term Psychiatric Effects of Antimalarial Drugs

EDITOR PICKS

SiteWatch: Washington University Expands Mission of McDonnell Genome Institute

Clinical Trials Software Vendor Teckro Raises $25 Million Series C

Stanford University Seeks Human Resources Administrator For the Cancer Clinical Trials Office

A Desperate Attempt to Save a Drug or a Positive Presentation Moving Forward?